Trial · NCT00968708
Adverse events1,464
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
61 to 80 of 1,464
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Cough | Respiratory, thoracic and mediastinal disorders | Placebo | 99 | 2,679 | |
| other | Cough | Respiratory, thoracic and mediastinal disorders | Alogliptin | 98 | 2,701 | |
| other | Dyspnoea | Respiratory, thoracic and mediastinal disorders | Placebo | 74 | 2,679 | |
| other | Dyspnoea | Respiratory, thoracic and mediastinal disorders | Alogliptin | 70 | 2,701 | |
| other | Hypertension | Vascular disorders | Placebo | 198 | 2,679 | |
| other | Hypertension | Vascular disorders | Alogliptin | 193 | 2,701 | |
| serious | Angina unstable | Cardiac disorders | Placebo | 142 | 2,679 | |
| serious | Angina unstable | Cardiac disorders | Alogliptin | 117 | 2,701 | |
| serious | Acute myocardial infarction | Cardiac disorders | Placebo | 104 | 2,679 | |
| serious | Acute myocardial infarction | Cardiac disorders | Alogliptin | 125 | 2,701 | |
| serious | Angina pectoris | Cardiac disorders | Placebo | 83 | 2,679 | |
| serious | Angina pectoris | Cardiac disorders | Alogliptin | 86 | 2,701 | |
| serious | Myocardial infarction | Cardiac disorders | Placebo | 54 | 2,679 | |
| serious | Myocardial infarction | Cardiac disorders | Alogliptin | 66 | 2,701 | |
| serious | Cardiac failure congestive | Cardiac disorders | Placebo | 53 | 2,679 | |
| serious | Cardiac failure congestive | Cardiac disorders | Alogliptin | 63 | 2,701 | |
| serious | Cardiac failure | Cardiac disorders | Placebo | 56 | 2,679 | |
| serious | Cardiac failure | Cardiac disorders | Alogliptin | 45 | 2,701 | |
| serious | Coronary artery disease | Cardiac disorders | Placebo | 34 | 2,679 | |
| serious | Coronary artery disease | Cardiac disorders | Alogliptin | 35 | 2,701 |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00968708/events?page=4